104 related articles for article (PubMed ID: 6354732)
1. A stimulatory effect of tolbutamide on the insulin-mediated glucose uptake in subjects with impaired glucose tolerance (IGT).
Schulz B; Ratzmann KP; Heinke P; Besch W
Exp Clin Endocrinol; 1983 Aug; 82(2):222-31. PubMed ID: 6354732
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of insulin resistance in non-obese subjects with impaired glucose tolerance.
Ratzmann KP; Witt S; Schulz B
Diabete Metab; 1982 Sep; 8(3):223-8. PubMed ID: 6754494
[TBL] [Abstract][Full Text] [Related]
3. Sulfonylurea therapy fails to diminish insulin resistance in type I-diabetic subjects.
Keller U; Müller R; Berger W
Horm Metab Res; 1986 Sep; 18(9):599-603. PubMed ID: 2946637
[TBL] [Abstract][Full Text] [Related]
4. Influence of continuous physiologic hyperinsulinemia on glucose kinetics and counterregulatory hormones in normal and diabetic humans.
Saccà L; Sherwin R; Hendler R; Felig P
J Clin Invest; 1979 May; 63(5):849-57. PubMed ID: 447832
[TBL] [Abstract][Full Text] [Related]
5. Metabolic and hormonal responses during a glucose controlled insulin infusion (Biostator) in subjects with impaired glucose tolerance.
Ratzmann KP; Schneider U; Peters U; Ziegler M; Schulz B
Exp Clin Endocrinol; 1984 May; 83(3):334-42. PubMed ID: 6381073
[TBL] [Abstract][Full Text] [Related]
6. Diurnal rhythm of insulin sensitivity in subjects with normal and impaired glucose tolerance.
Schulz B; Ratzmann KP; Albrecht G; Bibergeil H
Exp Clin Endocrinol; 1983 May; 81(3):263-72. PubMed ID: 6350027
[TBL] [Abstract][Full Text] [Related]
7. Effect of obesity on susceptibility to fatty acid-induced peripheral tissue insulin resistance.
Kruszynska YT; Olefsky JM; Frias JP
Metabolism; 2003 Feb; 52(2):233-8. PubMed ID: 12601639
[TBL] [Abstract][Full Text] [Related]
8. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
Adibi SA; Morse EL; Amin PM
J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
[TBL] [Abstract][Full Text] [Related]
9. Impact of incretin hormones on beta-cell function in subjects with normal or impaired glucose tolerance.
Muscelli E; Mari A; Natali A; Astiarraga BD; Camastra S; Frascerra S; Holst JJ; Ferrannini E
Am J Physiol Endocrinol Metab; 2006 Dec; 291(6):E1144-50. PubMed ID: 16478775
[TBL] [Abstract][Full Text] [Related]
10. Effect of chronic tolbutamide administration on normal and obese-hyperglycemic mice: evidence for post-receptor potentiation of insulin action.
Poyet C; Feldman JM
Res Commun Chem Pathol Pharmacol; 1982 Mar; 35(3):355-76. PubMed ID: 7043679
[TBL] [Abstract][Full Text] [Related]
11. Impaired basal glucose effectiveness but unaltered fasting glucose release and gluconeogenesis during short-term hypercortisolemia in healthy subjects.
Nielsen MF; Caumo A; Chandramouli V; Schumann WC; Cobelli C; Landau BR; Vilstrup H; Rizza RA; Schmitz O
Am J Physiol Endocrinol Metab; 2004 Jan; 286(1):E102-10. PubMed ID: 12965873
[TBL] [Abstract][Full Text] [Related]
12. Modulation of A and B cell functions by tolbutamide and arginine in the pancreas of thiamine-deficient rats.
Rathanaswami P; Sundaresan R
Biochem Int; 1989 Oct; 19(4):793-802. PubMed ID: 2695088
[TBL] [Abstract][Full Text] [Related]
13. Acute suppressive effect of human growth hormone on insulin release induced by glucagon and tolbutamide in man.
Adamson U; Cerasi E
Diabete Metab; 1975 Mar; 1():51-6. PubMed ID: 1234067
[TBL] [Abstract][Full Text] [Related]
14. Insulin receptor binding and insulin-mediated glucose uptake in type-II-diabetics.
Schulz B; Doberne L; Greenfield M; Reaven GM
Exp Clin Endocrinol; 1983 Jan; 81(1):49-58. PubMed ID: 6343099
[TBL] [Abstract][Full Text] [Related]
15. Tolbutamide-induced insulin release in pregnant diabetics.
Notelovitz M; James S
Horm Metab Res; 1977 May; 9(3):167-72. PubMed ID: 885466
[TBL] [Abstract][Full Text] [Related]
16. Sulfonylureas enhance in vivo the effectiveness of insulin in type 1 (insulin dependent) diabetes mellitus.
Pontiroli AE; Alberetto M; Bertoletti A; Baio G; Pozza G
Horm Metab Res; 1984 Dec; 16 Suppl 1():167-70. PubMed ID: 6398258
[TBL] [Abstract][Full Text] [Related]
17. Exogenous and endogenous insulin sensitivity following a single growth hormone injection.
Mahler RJ; Szabo O
Horm Metab Res; 1971 May; 3(3):155-60. PubMed ID: 5123991
[No Abstract] [Full Text] [Related]
18. Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes.
Ratzmann KP; Schulz B; Heinke P; Besch W
Diabetologia; 1984 Jul; 27(1):8-12. PubMed ID: 6147291
[TBL] [Abstract][Full Text] [Related]
19. Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects.
Pfeifer MA; Beard JC; Halter JB; Judzewitsch R; Best JD; Porte D
J Clin Endocrinol Metab; 1983 Mar; 56(3):586-91. PubMed ID: 6337181
[TBL] [Abstract][Full Text] [Related]
20. Stimulatory effects of tolbutamide infusion on plasma glucagon in insulin-dependent diabetic subjects.
Bohannon NV; Lorenzi M; Grodsky GM; Karam JH
J Clin Endocrinol Metab; 1982 Feb; 54(2):459-62. PubMed ID: 7054228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
